BCL2 and lung carcinoma: To further elucidate the apoptotic mechanism induced by isalpinin, the expression levels of the antiapoptotic protein Bcl-2 were examined in H23 and H460 lung cancer cells after a 24 h treatment with isalpinin at concentrations of 0, 20, 30, and 40 μM.